When selecting all patients with luminal PAM50 tumours, regardless of ER/HER2 status (n = 274), the findings after 10 years of follow-up were essentially the same (interaction: HRBCFi: 0.45, 95% CI: 0.21–0.96, P = 0.04)). The gene discussed is ERBB2; the disease is neoplasm.